MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹6,022 Cr | ₹8,300 Cr | ₹196 Cr | ₹163 Cr | ₹868 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹6,022 Cr |
| Mar2025 | ₹8,300 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹868 Cr |
How is Total Debt of MANKIND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,022 Cr | -27.45 | |
| Mar2025 | ₹8,300 Cr | 4,134.07 | |
| Mar2024 | ₹196 Cr | 20.54 | |
| Mar2023 | ₹163 Cr | -81.26 | |
| Mar2022 | ₹868 Cr | - | |
Compare Total Debt of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹105,608.2 Cr | -0% | 0.3% | -2.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0% |
0.3% |
-2.8% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses